Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study-Reference-Cited by-同舟云学术

Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study

Published:2022-09-18 Issue:14 Volume:63 Page:3456-3461
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Joshi Utsav¹^ORCID,Bhattarai Adheesh²,Gaire Suman³,Gill Simrat¹,Agrawal Vishakha²,Yadav Sumeet Kumar⁴,Low Soon Khai¹,Dhakal Prajwal⁵^ORCID,Bhatt Vijaya Raj⁶⁷,Kouides Peter A.⁸⁹

Affiliation:

1. Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA

2. Department of Internal Medicine, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal

3. Department of Internal Medicine, Mount Sinai Hospital, Chicago, IL, USA

4. Department of Hospital Internal Medicine, Mayo Clinic Health System, Mankato, MN, USA

5. Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA, USA

6. Department of Internal Medicine, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA

7. Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA

8. Division of Hematology and Clinical Oncology, Rochester General Hospital, Rochester, NY, USA

9. University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2123227

Reference26 articles.

1. American Cancer Society. Cancer treatment & survivorship facts & figures 2019–2021; [cited 2022 May 8]. Available from: https://www.cancer.org/research/cancer-facts-statistics/survivor-facts-figures.html

2. The Rising Incidence of Second Cancers: Patterns of Occurrence and Identification of Risk Factors for Children and Adults

3. Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications

4. Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors—A Literature Review;Journal of Clinical Medicine;2024-08-01

2. Refining patients’ care in myelofibrosis: looking at second primary malignancies;Leukemia & Lymphoma;2022-12-06